Have been postive on this one for quite some time however, paitence is now wearing thin for NY and EXR. Management need to work harder on activly communicating progress and how the investors money is being utilised. A sustained -60% SP decline over 12 months is a terrible result for any company. Short term poor performance is now becomming mid term. It's only the long term view of holders keeping the SP from capitulation. NY should be on the front foot communicating with holders. There are various mediums for this other than ASX announcements. NY did well to promote the CR, I would like the same effort put into promotion of the company, build belief that the discoveries are going to be commercially extractable.
There are too many sycophants cutting slack for management. The communication is night and day between 20/21 and 21/22 along with the SP.
EXR Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
